Discontinued — last reported Q3 '24
Carelon Total — Reportable segments’ operating gain
Elevance Health Carelon Total — Reportable segments’ operating gain increased by 13.9% to $803.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 23.5%, from $650.00M to $803.00M. Over 2 years (FY 2021 to FY 2023), Carelon Total — Reportable segments’ operating gain shows an upward trend with a 21.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase signals improved margins or better cost control, while a decrease may indicate rising medical loss ratios or operational inefficiencies.
Detailed definition
This metric represents the operating profit generated by the business segment after deducting direct operating expenses...
Peer comparison
Comparable to 'Operating Income' or 'Segment Earnings' reported by peers in the managed care industry.
elv_segment_total_reportable_segments_operating_gainHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $450.50M | $450.50M | $450.50M | $598.00M | $592.00M | $641.00M | $492.00M | $721.00M | $632.00M | $650.00M | $652.00M | $813.00M | $705.00M | $803.00M |
| QoQ Change | — | +0.0% | +0.0% | +32.7% | -1.0% | +8.3% | -23.2% | +46.5% | -12.3% | +2.8% | +0.3% | +24.7% | -13.3% | +13.9% |
| YoY Change | — | — | — | — | +31.4% | +42.3% | +9.2% | +20.6% | +6.8% | +1.4% | +32.5% | +12.8% | +11.6% | +23.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelon total — reportable segments’ operating gain?
- Elevance Health (ELV) reported carelon total — reportable segments’ operating gain of $803.00M in Q3 2024.
- How has Elevance Health's carelon total — reportable segments’ operating gain changed year-over-year?
- Elevance Health's carelon total — reportable segments’ operating gain increased by 23.5% year-over-year, from $650.00M to $803.00M.
- What is the long-term trend for Elevance Health's carelon total — reportable segments’ operating gain?
- Over 2 years (2021 to 2023), Elevance Health's carelon total — reportable segments’ operating gain has grown at a 21.4% compound annual growth rate (CAGR), from $1.80B to $2.66B.
- What does carelon total — reportable segments’ operating gain mean?
- The profit earned by the business segment from its core operations before interest and taxes.